CalculatorNephrology
Phenytoin correction in end-stage kidney disease (Winter-Tozer)
Adjusts measured total phenytoin for albumin and the reduced protein binding of uraemia.
Updated 30 October 2026
When to use it
Patients with end-stage kidney disease, on haemodialysis or with marked uraemia (clearance < 10 mL/min) when free phenytoin is not available.
Warning
Rough estimate: it does not replace free phenytoin measurement or clinical judgement.
What it needs
- Measured total phenytoin
- Serum albumin
Formula
Classic: corrected phenytoin = measured / (0.1 × albumin [g/dL] + 0.1)
Revised (Soriano 2017): measured / (0.2 × albumin [g/dL] + 0.1)
How to interpret it
| Result | Interpretation |
|---|---|
| < 10 | Below the therapeutic range (10–20 mg/L) |
| 10 to < 20 | Within the therapeutic range |
| 20 to < 30 | Above the range: risk of toxicity |
| ≥ 30 | Very high: toxicity likely |
In the app it also calculates: Corrected phenytoin (revised equation).
Practical tip
In uraemia phenytoin binds poorly to albumin: a "normal" total level may hide a toxic free fraction.
2 more practical tips in the app.
Reference
- Liponi DF, Winter ME, Tozer TN. Renal function and therapeutic concentrations of phenytoin. Neurology. 1984;34(3):395-397.
- Soriano VV, Tesoro EP, Kane SP. Characterization of free phenytoin concentrations in end-stage renal disease using the Winter-Tozer equation. Ann Pharmacother. 2017;51(8):669-674.
A support tool for healthcare professionals: it guides and does not replace clinical judgement.
